ライフサイエンスコーパス: tumor staging

1 ive imaging of sentinel lymph nodes in solid tumor staging.

2 in molecular characteristics with pathologic tumor staging.

3 manuals introduced greater granularity to HN tumor staging.

4 hen combined with serum alpha fetoprotein or tumor staging.

5 essed clinical relevance based on changes in tumor staging.

6 tentially reduces additional examinations in tumor staging.

7 the accuracy of CT, MR, and scintigraphy for tumor staging.

8 Both CT and MR perform poorly for local tumor staging.

9 I should be considered for inclusion in CSCC tumor staging.

10 ding real-time monitoring of endocytosis and tumor staging.

11 PET/CT imaging is a significant pitfall for tumor staging.

12 oma would result in inconsistencies in final tumor staging.

13 TE PET/CT were follow-up (24.4%) and initial tumor staging (23.4%).

14 nts underwent laparoscopy after conventional tumor staging; 89 were also staged with laparoscopic ult

15 Tumor staging according to the American Joint Committee

16 copic ultrasonography was superior to CT for tumor staging accuracy (67% vs. 41%; P < 0.001) but equi

17 Interobserver agreement was excellent for tumor staging (American Joint Committee on Cancer/Union

18 ogist is critical for patient management for tumor staging and assessing treatment response.

19 menopausal status, comorbidity estimate) and tumor staging and characteristics (tumor size, number of

20 he significant association of synuclein with tumor staging and clinical outcome (P = .002).

21 t imaging to provide detailed information on tumor staging and grading, evaluating treatment, and det

22 data indicate that locoregional LND improves tumor staging and leads to a favorable oncologic outcome

23 ndergoing eye-preserving therapies relies on tumor staging and molecular analysis of tumor tissue obt

24 the selection of infiltrated lymph nodes for tumor staging and pathology was thus tested.

25 ancer cells circulating in blood may improve tumor staging and patient selection for targeted therapy

26 lating cell-free DNA (cfDNA) correlates with tumor staging and prognosis.

27 ost-LT surveillance, provide a framework for tumor staging and risk stratification, and select candid

28 calculated any differences in diagnosis and tumor staging and the potential impact of differences in

29 stasis is the dominant prognostic factor for tumor staging and therapeutic decision-making.

30 vasive manner, providing new readouts to aid tumor staging and treatment decision making.

31 The examinations were performed in terms of tumor staging and, in some instances, also of primary tu

32 Overall survival correlated with tumor staging, and 92% of patients were diagnosed with a

33 sues, which were associated with HPV status, tumor staging, and anatomic locations.

34 iation therapy, and surgery), refinements in tumor staging, and better supportive care have significa

35 ified modified FOLFIRINOX, age, tumor grade, tumor staging, and larger-volume center as significant f

36 n, their distinctive patterns in relation to tumor staging, and their recurrence across different tum

37 Treatment strategies should be affected by tumor staging at presentation.

38 lymph nodes has become a well-known issue in tumor staging by (18)F-FDG PET/CT.

39 uveal melanoma and adequate records to allow tumor staging by American Joint Committee on Cancer (AJC

40 to April 1, 2011, adequate records to allow tumor staging by the AJCC criteria, and follow-up for me

41 and a prognostic score-integrating ITA.LI.CA tumor staging, CPS, ECOG performance status, and AFP.

42 data, demographics, histologic diagnoses and tumor staging data were collected.

43 s product, C24-Ceramide, was associated with tumor staging, distal metastasis, and worse prognosis.

44 mages from 78 patients who were referred for tumor staging for the presence of vascular (18)F-FDG upt

45 hogenesis of HCC may provide new markers for tumor staging, for assessment of the relative risk of tu

46 Accurate rectal tumor staging guides the choice of treatment options.

47 r characteristics such as tumor progression, tumor staging, heterogeneity, gene mutations, and clonal

48 Based on tumor staging (I, II, III, and IV), features that showed

49 Specific indications may include tumor staging, identifying patients who would benefit fr

50 e current literature on (18)F-FDG PET/CT for tumor staging in children, summarizing questions that ha

51 atures that showed significant increase with tumor staging included age at presentation (57, 58, 60,

52 ole, as it allows the pathologist to provide tumor-staging information necessary for an appropriate c

53 Present tumor staging is mainly based on local tumor extension,

54 As we develop new approaches for tumor staging, it is important to understand current ben

55 ted in CMS4 CRC patients and associated with tumor staging, lymph node and distant metastasis.

56 pression in human colon cancer in respect to tumor staging, NOS-expressing cell type(s), nitrotyrosin

57 Pathologic tumor staging of the explanted liver was based on the Am

58 Tumor staging on the basis of the PET/CT and MR/PET stud

59 es of disease, surpassing in accuracy either tumor staging or loss of p27(KIP1) as a negative prognos

60 es who received imaging with (68)Ga-FAPI for tumor staging or restaging between October 2018 and Marc

61 rs, potentially opening new applications for tumor staging or restaging.

62 Commonly used for tumor staging, PET/CT aided in the detection of the prim

63 The overall change in tumor staging rate was 24% (97 of 405 patients; 95% CI,

64 at all stages of the pathway, such as local tumor staging/restaging, creating an imaging-based "road

65 with better patient survival independent of tumor staging, site location, microsatellite instability

66 ITA.LI.CA prognostic system includes both a tumor staging-stratifying patients with HCC into six mai

67 udy have prompted the development of a novel tumor staging system based on TVI.

68 This study proposes an alternative tumor staging system for cutaneous squamous cell carcino

69 The proposed alternative tumor staging system offers improved prognostic discrimi

70 An alternative tumor staging system was developed with the aim of bette

71 entral to management, and physicians rely on tumor staging systems to estimate risk.

72 ith log-rank testing for evaluation of the 2 tumor staging systems.

73 Multivariate analysis incorporating tumor staging, treatment status, and smoking history rev

74 algorithms rendered an 89%-correct rate for tumor staging using genes differentially expressed betwe

75 Tumor staging was similar between groups.

76 liary body and choroidal) melanoma, the AJCC tumor staging was stage I in 2767 (36%), stage II in 373

77 patients who underwent (18)F-FDG PET/CT for tumor staging were identified from a database search.

78 Metastasis after initial tumor staging with 5- and 10-year Kaplan-Meier metastasi

79 red for hepatic resection after conventional tumor staging with computed tomography.

80 ng to Union for International Cancer Control tumor staging with patients who completed AT.

81 (68)Ga-FAPI is a new tool for tumor staging with theranostic potential.

82 Laparoscopic US allows tumor staging without formal celiotomy, and many hepatic